← Eichor
Study identifier: NCT06203106 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

NYSCF Scientific Discovery Biobank

Condition: ALS · Amyotrophic Lateral Sclerosis · Alzheimer Disease  ·  Sponsor: New York Stem Cell Foundation Research Institute

PhaseN/A
Planned participants10000
Who can joinAll sexes, 30 Days to no upper limit
Healthy volunteersNo

About this study

The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for the major diseases of our time.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Research Office  ·  212-927-1801  ·  clinicalresearch@nyscf.org

Always discuss trial participation with your own doctor first.

Locations (1)

New York Stem Cell Foundation Research InstituteNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06203106